Risk of skin reactions when using ibuprofen-based medicines

Author： Sánchez-Borges Mario Capriles-Hulett Arnaldo Caballero-Fonseca Fernan

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.5, 2005-09, pp. : 837-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adverse Drug Reactions: When the Risk Becomes a Reality for Patients

By Cox Anthony R. Butt Tehreem F.

Drug Safety, Vol. 35, Iss. 11, 2012-11 ,pp. : 977-981

Adis International

Access to resources Recommend Favorite

Exploring Nanotechnologies for the Effective Therapy of Malaria Using Plant-Based Medicines

Current Pharmaceutical Design, Vol. 22, Iss. 27, 2016-08 ,pp. : 4232-4246

Bentham Science Publishers

Access to resources Recommend Favorite

Cetirizine and Loratadine: a Comparison Using the ED₅₀ in Skin Reactions

By Ramboer I Bumbacea R Lazarescu D Radu JR

The Journal of International Medical Research, Vol. 28, Iss. 2, 2000-03 ,pp. : 69-77

Field House Publishing

Access to resources Recommend Favorite

Risk Management of Medicines and Compensation for Harm

By Edwards I. Ralph

Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. : 87-90

Adis International

Access to resources Recommend Favorite

Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data

By Griem P. Goebel C. Scheffler H.

Regulatory Toxicology and Pharmacology, Vol. 38, Iss. 3, 2003-12 ,pp. : 269-290

Elsevier

Access to resources Recommend Favorite